Frontlight ResearchEarly access
Chronic kidney disease trials in Lithuania
5 of 6 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Alytus, Jonava, Kaunas, Kovno, Vilnius
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - Phase 3Active, not recruitingA Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
- Where
- Kaunas, Vilnius
- Age
- 1 year to 18 years
- People
- 100 worldwide
- Run by
- Bayer
See details and how to joinNCT05457283 · EU 2023-504885-50-00 - Phase 3TerminatedA Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
- Where
- Vilinus
- Age
- 2 years to 17 years
- People
- 24 worldwide
- Run by
- Amgen
See details and how to joinNCT03969329 · EU 2023-506471-10-00 - Phase 3Taking peopleA Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- Where
- Vilnius
- Age
- 2 years to 17 years
- People
- 129 worldwide
- Run by
- AMAG Pharmaceuticals, Inc.
See details and how to joinNCT03619850 · EU 2024-516263-92-00 - No phaseNot yet taking people in LithuaniaPhysical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
- Where
- Kaunas
- Age
- 18 years and over
- People
- 124 worldwide
- Run by
- Biogem s.c.ar.l.
See details and how to joinNCT07160959